Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations and Comprehensive Loss

v3.22.2
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2022
Jun. 30, 2021
Jun. 30, 2022
Jun. 30, 2021
Operating expenses:        
Research and development $ 3,229,584 $ 754,302 $ 5,132,416 $ 973,893
General and administrative 1,635,065 351,114 3,670,751 699,492
Total operating expenses 4,864,649 1,105,416 8,803,167 1,673,385
Loss from operations (4,864,649) (1,105,416) (8,803,167) (1,673,385)
Other income (expense):        
Interest expense, net 134,291 133,686 282,064 135,405
Change in fair value of financial instruments 930,193 1,013,880 2,910,865 (4,523,685)
Gain on extinguishment of convertible debt and derivative liability 1,307,421   1,307,421  
Other income/(expense) 16,288 (321) 27,062 (2,379)
Total other income (expense), net 2,119,611 879,873 3,963,284 (4,661,469)
Net loss (2,745,038) (225,543) (4,839,883) (6,334,854)
Other comprehensive gain/(loss):        
Gain/(loss) on foreign currency translation 1,636 (91,842) 49,477 (145,217)
Comprehensive loss $ (2,743,402) $ (317,385) $ (4,790,406) $ (6,480,071)
Net loss per Common Share, basic $ (0.38) $ (0.06) $ (0.67) $ (1.30)
Net loss per Common Share, diluted $ (0.38) $ (0.06) $ (0.67) $ (1.30)
Weighted-average Common Shares, basic 7,195,529 5,099,172 7,195,529 5,000,935
Weighted-average Common Shares, diluted 7,195,529 5,099,172 7,195,529 5,000,935